Loading…

Monoclonal gammopathy of renal significance (MGRS): the characteristics and significance of a new meta-entity

Monoclonal gammopathy of renal significance (MGRS) is a new nosological group of entities (meta-entity) defined in 2012, whose pathogenesis depends on monoclonal immunoglobulins (Ig) secreted by low-grade lymphoproliferative disorders, which belong to M-protein-related diseases. Renal damage is the...

Full description

Saved in:
Bibliographic Details
Published in:International urology and nephrology 2017-12, Vol.49 (12), p.2171-2175
Main Authors: Ciocchini, Mariana, Arbelbide, Jorge, Musso, Carlos G.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c372t-2c8018bf491d3c23490c96ba65869275c9e283b1898f18404ae36f8ce1e806dc3
cites cdi_FETCH-LOGICAL-c372t-2c8018bf491d3c23490c96ba65869275c9e283b1898f18404ae36f8ce1e806dc3
container_end_page 2175
container_issue 12
container_start_page 2171
container_title International urology and nephrology
container_volume 49
creator Ciocchini, Mariana
Arbelbide, Jorge
Musso, Carlos G.
description Monoclonal gammopathy of renal significance (MGRS) is a new nosological group of entities (meta-entity) defined in 2012, whose pathogenesis depends on monoclonal immunoglobulins (Ig) secreted by low-grade lymphoproliferative disorders, which belong to M-protein-related diseases. Renal damage is the result of monoclonal Ig deposit or its activity as autoantibodies, which can compromise any nephronal area. MGRS does not include kidney diseases produced by high-grade lymphoproliferative disorders as well as those whose pathogenesis are independent of monoclonal Ig (such as drug toxicity or metabolic disorders). The importance of this hemato-nephrological meta-entity is based on two aspects: First, it is associated with increased morbidity and mortality, including recurrence in post-renal transplant or its appearance as “de novo” after it; and second, it usually improves after treating the plasmocyte or lymphocyte clone responsible, leading to the elimination of M-protein. Between low-grade lymphoproliferative disorders, monoclonal gammopathy of undetermined significance (MGUS) requires special consideration for two reasons: First, it is the disorder most related to MGRS; second, when MGUS progresses to MGRS, effective treatment against toxic underline clone should be performed taking into account the nephrological perspective.
doi_str_mv 10.1007/s11255-017-1594-y
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1959137735</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1959137735</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-2c8018bf491d3c23490c96ba65869275c9e283b1898f18404ae36f8ce1e806dc3</originalsourceid><addsrcrecordid>eNp1kE1LAzEQhoMoWj9-gBcJeNFDdCbZ7CbeRLQKFsGPc0jTbLvS3a1Jiuy_d0ur6MHTwMwz7zAPIccIFwhQXEZELiUDLBhKnbFuiwxQFoJxqbJtMgAByDDnYo_sx_gOAFoB7JI9rjIuocgHpB61TevmbWPndGrrul3YNOtoW9LgV71YTZuqrJxtnKdno-Hzy_kVTTNP3cwG65IPVUyVi9Q2k79wH2Fp4z9p7ZNlvklV6g7JTmnn0R9t6gF5u7t9vblnj0_Dh5vrR-ZEwRPjTgGqcZlpnAjHRabB6Xxsc6lyzQvptOdKjFFpVaLKILNe5KVyHr2CfOLEATld5y5C-7H0MZn3dhn6f6JBLTWKohCyp3BNudDGGHxpFqGqbegMglkJNmvBphdsVoJN1--cbJKX49pPfja-jfYAXwOxHzVTH36d_jf1C231hho</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1959137735</pqid></control><display><type>article</type><title>Monoclonal gammopathy of renal significance (MGRS): the characteristics and significance of a new meta-entity</title><source>Springer Nature</source><creator>Ciocchini, Mariana ; Arbelbide, Jorge ; Musso, Carlos G.</creator><creatorcontrib>Ciocchini, Mariana ; Arbelbide, Jorge ; Musso, Carlos G.</creatorcontrib><description>Monoclonal gammopathy of renal significance (MGRS) is a new nosological group of entities (meta-entity) defined in 2012, whose pathogenesis depends on monoclonal immunoglobulins (Ig) secreted by low-grade lymphoproliferative disorders, which belong to M-protein-related diseases. Renal damage is the result of monoclonal Ig deposit or its activity as autoantibodies, which can compromise any nephronal area. MGRS does not include kidney diseases produced by high-grade lymphoproliferative disorders as well as those whose pathogenesis are independent of monoclonal Ig (such as drug toxicity or metabolic disorders). The importance of this hemato-nephrological meta-entity is based on two aspects: First, it is associated with increased morbidity and mortality, including recurrence in post-renal transplant or its appearance as “de novo” after it; and second, it usually improves after treating the plasmocyte or lymphocyte clone responsible, leading to the elimination of M-protein. Between low-grade lymphoproliferative disorders, monoclonal gammopathy of undetermined significance (MGUS) requires special consideration for two reasons: First, it is the disorder most related to MGRS; second, when MGUS progresses to MGRS, effective treatment against toxic underline clone should be performed taking into account the nephrological perspective.</description><identifier>ISSN: 0301-1623</identifier><identifier>EISSN: 1573-2584</identifier><identifier>DOI: 10.1007/s11255-017-1594-y</identifier><identifier>PMID: 28425076</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>Autoantibodies ; Benign monoclonal gammopathy ; Humans ; Immunoglobulin Light Chains - blood ; Immunoglobulins ; Immunoproliferative diseases ; Kidney Diseases - blood ; Kidney Diseases - etiology ; Kidney Diseases - pathology ; Kidney transplantation ; Lymphocytes ; Medicine ; Medicine &amp; Public Health ; Metabolic disorders ; Monoclonal antibodies ; Monoclonal Gammopathy of Undetermined Significance - blood ; Monoclonal Gammopathy of Undetermined Significance - complications ; Monoclonal Gammopathy of Undetermined Significance - pathology ; Morbidity ; Nephrology ; Nephrology – Review ; Pathogenesis ; Toxicity ; Urology</subject><ispartof>International urology and nephrology, 2017-12, Vol.49 (12), p.2171-2175</ispartof><rights>Springer Science+Business Media Dordrecht 2017</rights><rights>International Urology and Nephrology is a copyright of Springer, 2017.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-2c8018bf491d3c23490c96ba65869275c9e283b1898f18404ae36f8ce1e806dc3</citedby><cites>FETCH-LOGICAL-c372t-2c8018bf491d3c23490c96ba65869275c9e283b1898f18404ae36f8ce1e806dc3</cites><orcidid>0000-0002-8550-9564</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28425076$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ciocchini, Mariana</creatorcontrib><creatorcontrib>Arbelbide, Jorge</creatorcontrib><creatorcontrib>Musso, Carlos G.</creatorcontrib><title>Monoclonal gammopathy of renal significance (MGRS): the characteristics and significance of a new meta-entity</title><title>International urology and nephrology</title><addtitle>Int Urol Nephrol</addtitle><addtitle>Int Urol Nephrol</addtitle><description>Monoclonal gammopathy of renal significance (MGRS) is a new nosological group of entities (meta-entity) defined in 2012, whose pathogenesis depends on monoclonal immunoglobulins (Ig) secreted by low-grade lymphoproliferative disorders, which belong to M-protein-related diseases. Renal damage is the result of monoclonal Ig deposit or its activity as autoantibodies, which can compromise any nephronal area. MGRS does not include kidney diseases produced by high-grade lymphoproliferative disorders as well as those whose pathogenesis are independent of monoclonal Ig (such as drug toxicity or metabolic disorders). The importance of this hemato-nephrological meta-entity is based on two aspects: First, it is associated with increased morbidity and mortality, including recurrence in post-renal transplant or its appearance as “de novo” after it; and second, it usually improves after treating the plasmocyte or lymphocyte clone responsible, leading to the elimination of M-protein. Between low-grade lymphoproliferative disorders, monoclonal gammopathy of undetermined significance (MGUS) requires special consideration for two reasons: First, it is the disorder most related to MGRS; second, when MGUS progresses to MGRS, effective treatment against toxic underline clone should be performed taking into account the nephrological perspective.</description><subject>Autoantibodies</subject><subject>Benign monoclonal gammopathy</subject><subject>Humans</subject><subject>Immunoglobulin Light Chains - blood</subject><subject>Immunoglobulins</subject><subject>Immunoproliferative diseases</subject><subject>Kidney Diseases - blood</subject><subject>Kidney Diseases - etiology</subject><subject>Kidney Diseases - pathology</subject><subject>Kidney transplantation</subject><subject>Lymphocytes</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Metabolic disorders</subject><subject>Monoclonal antibodies</subject><subject>Monoclonal Gammopathy of Undetermined Significance - blood</subject><subject>Monoclonal Gammopathy of Undetermined Significance - complications</subject><subject>Monoclonal Gammopathy of Undetermined Significance - pathology</subject><subject>Morbidity</subject><subject>Nephrology</subject><subject>Nephrology – Review</subject><subject>Pathogenesis</subject><subject>Toxicity</subject><subject>Urology</subject><issn>0301-1623</issn><issn>1573-2584</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp1kE1LAzEQhoMoWj9-gBcJeNFDdCbZ7CbeRLQKFsGPc0jTbLvS3a1Jiuy_d0ur6MHTwMwz7zAPIccIFwhQXEZELiUDLBhKnbFuiwxQFoJxqbJtMgAByDDnYo_sx_gOAFoB7JI9rjIuocgHpB61TevmbWPndGrrul3YNOtoW9LgV71YTZuqrJxtnKdno-Hzy_kVTTNP3cwG65IPVUyVi9Q2k79wH2Fp4z9p7ZNlvklV6g7JTmnn0R9t6gF5u7t9vblnj0_Dh5vrR-ZEwRPjTgGqcZlpnAjHRabB6Xxsc6lyzQvptOdKjFFpVaLKILNe5KVyHr2CfOLEATld5y5C-7H0MZn3dhn6f6JBLTWKohCyp3BNudDGGHxpFqGqbegMglkJNmvBphdsVoJN1--cbJKX49pPfja-jfYAXwOxHzVTH36d_jf1C231hho</recordid><startdate>20171201</startdate><enddate>20171201</enddate><creator>Ciocchini, Mariana</creator><creator>Arbelbide, Jorge</creator><creator>Musso, Carlos G.</creator><general>Springer Netherlands</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><orcidid>https://orcid.org/0000-0002-8550-9564</orcidid></search><sort><creationdate>20171201</creationdate><title>Monoclonal gammopathy of renal significance (MGRS): the characteristics and significance of a new meta-entity</title><author>Ciocchini, Mariana ; Arbelbide, Jorge ; Musso, Carlos G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-2c8018bf491d3c23490c96ba65869275c9e283b1898f18404ae36f8ce1e806dc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Autoantibodies</topic><topic>Benign monoclonal gammopathy</topic><topic>Humans</topic><topic>Immunoglobulin Light Chains - blood</topic><topic>Immunoglobulins</topic><topic>Immunoproliferative diseases</topic><topic>Kidney Diseases - blood</topic><topic>Kidney Diseases - etiology</topic><topic>Kidney Diseases - pathology</topic><topic>Kidney transplantation</topic><topic>Lymphocytes</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Metabolic disorders</topic><topic>Monoclonal antibodies</topic><topic>Monoclonal Gammopathy of Undetermined Significance - blood</topic><topic>Monoclonal Gammopathy of Undetermined Significance - complications</topic><topic>Monoclonal Gammopathy of Undetermined Significance - pathology</topic><topic>Morbidity</topic><topic>Nephrology</topic><topic>Nephrology – Review</topic><topic>Pathogenesis</topic><topic>Toxicity</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ciocchini, Mariana</creatorcontrib><creatorcontrib>Arbelbide, Jorge</creatorcontrib><creatorcontrib>Musso, Carlos G.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>International urology and nephrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ciocchini, Mariana</au><au>Arbelbide, Jorge</au><au>Musso, Carlos G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Monoclonal gammopathy of renal significance (MGRS): the characteristics and significance of a new meta-entity</atitle><jtitle>International urology and nephrology</jtitle><stitle>Int Urol Nephrol</stitle><addtitle>Int Urol Nephrol</addtitle><date>2017-12-01</date><risdate>2017</risdate><volume>49</volume><issue>12</issue><spage>2171</spage><epage>2175</epage><pages>2171-2175</pages><issn>0301-1623</issn><eissn>1573-2584</eissn><abstract>Monoclonal gammopathy of renal significance (MGRS) is a new nosological group of entities (meta-entity) defined in 2012, whose pathogenesis depends on monoclonal immunoglobulins (Ig) secreted by low-grade lymphoproliferative disorders, which belong to M-protein-related diseases. Renal damage is the result of monoclonal Ig deposit or its activity as autoantibodies, which can compromise any nephronal area. MGRS does not include kidney diseases produced by high-grade lymphoproliferative disorders as well as those whose pathogenesis are independent of monoclonal Ig (such as drug toxicity or metabolic disorders). The importance of this hemato-nephrological meta-entity is based on two aspects: First, it is associated with increased morbidity and mortality, including recurrence in post-renal transplant or its appearance as “de novo” after it; and second, it usually improves after treating the plasmocyte or lymphocyte clone responsible, leading to the elimination of M-protein. Between low-grade lymphoproliferative disorders, monoclonal gammopathy of undetermined significance (MGUS) requires special consideration for two reasons: First, it is the disorder most related to MGRS; second, when MGUS progresses to MGRS, effective treatment against toxic underline clone should be performed taking into account the nephrological perspective.</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><pmid>28425076</pmid><doi>10.1007/s11255-017-1594-y</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0002-8550-9564</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0301-1623
ispartof International urology and nephrology, 2017-12, Vol.49 (12), p.2171-2175
issn 0301-1623
1573-2584
language eng
recordid cdi_proquest_journals_1959137735
source Springer Nature
subjects Autoantibodies
Benign monoclonal gammopathy
Humans
Immunoglobulin Light Chains - blood
Immunoglobulins
Immunoproliferative diseases
Kidney Diseases - blood
Kidney Diseases - etiology
Kidney Diseases - pathology
Kidney transplantation
Lymphocytes
Medicine
Medicine & Public Health
Metabolic disorders
Monoclonal antibodies
Monoclonal Gammopathy of Undetermined Significance - blood
Monoclonal Gammopathy of Undetermined Significance - complications
Monoclonal Gammopathy of Undetermined Significance - pathology
Morbidity
Nephrology
Nephrology – Review
Pathogenesis
Toxicity
Urology
title Monoclonal gammopathy of renal significance (MGRS): the characteristics and significance of a new meta-entity
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T20%3A24%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Monoclonal%20gammopathy%20of%20renal%20significance%20(MGRS):%20the%20characteristics%20and%20significance%20of%20a%20new%20meta-entity&rft.jtitle=International%20urology%20and%20nephrology&rft.au=Ciocchini,%20Mariana&rft.date=2017-12-01&rft.volume=49&rft.issue=12&rft.spage=2171&rft.epage=2175&rft.pages=2171-2175&rft.issn=0301-1623&rft.eissn=1573-2584&rft_id=info:doi/10.1007/s11255-017-1594-y&rft_dat=%3Cproquest_cross%3E1959137735%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c372t-2c8018bf491d3c23490c96ba65869275c9e283b1898f18404ae36f8ce1e806dc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1959137735&rft_id=info:pmid/28425076&rfr_iscdi=true